NCT03704207NARecruiting
Utility of PCD Diagnostics to Improve Clinical Care
Vanderbilt University Medical Center
Start Date
6/1/2017
Completion Date
6/1/2028
Summary
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Detailed Description
This study is a prospective data collection of individuals referred to the investigators clinical center for considerations of PCD. Participants sign informed consent to have clinical information entered into a secure electronic database. As part of this study, participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research procedure, but it is a test with growing utility for making a diagnosis of PCD when performed in the right clinical setting.
Eligibility Criteria
Age Range: 1 years to No maximum
Inclusion Criteria:
* Referred to center for PCD diagnosis considerations
* Ability to perform study procedures
* Age greater than 2 years of age
Exclusion Criteria:
* Age less than 2 years of age Inability to perform informed consent
Interventions
OTHER
nNO testing
Conditions
Primary Ciliary Dyskinesia
Locations
Vanderbilt Children's hospital
Nashville, Tennessee 37232
United States